(Q51939874)

18 April 2018

title

Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. (English)

1 reference

18 April 2018

0 references

1 reference

3

1 reference

18 April 2018

Bernard H Bochner

7

1 reference

18 April 2018

author name string

Atreya Dash

1

1 reference

18 April 2018

Matthew D Galsky

2

1 reference

18 April 2018

Angel M Serio

4

1 reference

18 April 2018

Theresa M Koppie

5

1 reference

18 April 2018

Guido Dalbagni

6

1 reference

18 April 2018

language of work or name

English

0 references

publication date

1 August 2006

1 reference

18 April 2018

published in

Cancer

1 reference

18 April 2018

volume

107

1 reference

18 April 2018

page(s)

506-513

1 reference

18 April 2018

issue

3

1 reference

18 April 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

Natural history of surgically treated bladder carcinoma with extravesical tumor extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Advanced Bladder Cancer (Stages pT3b, pT4a, pN1 and pN2): Improved Survival after Radical Cystectomy and 3 Adjuvant Cycles of Chemotherapy. Results of a Controlled Prospective Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Update on chemotherapy for advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Overview of bladder cancer trials in the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Estimation of creatinine clearance when urine cannot be collected.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Estimation of the glomerular filtration rate in cancer patients: a new formula for new drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Perioperative chemotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Benefit of radical cystectomy in the elderly patient with significant co-morbidities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Radical cystectomy in the elderly: Comparison of survival between younger and older patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Estimation of glomerular filtration rate in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Orthotopic ileal neobladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Postoperative resorptive and excretory capacity of the ileal neobladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22031

7 January 2021

Identifiers

DOI

10.1002/CNCR.22031

1 reference

18 April 2018

PubMed ID

16773629

1 reference

18 April 2018